Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial. [electronic resource]
Producer: 20200622Description: 109-117 p. digitalISSN:- 1873-1740
- Anti-HIV Agents -- adverse effects
- Attitude of Health Personnel
- Cardiovascular Diseases -- diagnosis
- Drug Prescriptions
- Economics, Behavioral
- Education, Medical, Continuing
- HIV Infections -- diagnosis
- HIV Long-Term Survivors -- psychology
- Health Knowledge, Attitudes, Practice
- Health Status
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Implementation Science
- Inservice Training
- Los Angeles -- epidemiology
- Medication Adherence
- Multicenter Studies as Topic
- Patient Education as Topic
- Practice Patterns, Physicians'
- Preventive Health Services
- Protective Factors
- Randomized Controlled Trials as Topic
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.